 |
|
|
| |
Simeprevir (TMC435) in combination with peginterferon/ribavirin in patients
co-infected with HCV genotype-1 and HIV-1: Primary analysis of the C212 study
|
| |
| |
Reported by Jules Levin
14th European AIDS Conference (EACS)
16-19 October 2013 · Brussels, Belgium
Douglas Dieterich,1 Jürgen Rockstroh,2 Chloe Orkin,3 Félix Gutiérrez,4 Marina B Klein,5 Jacques Reynes,6 Wolfgang Jessner,7 Alan Jenkins,8 Oliver Lenz,7 Sivi Ouwerkerk-Mahadevan,7 Monika Peeters,7 Guy De La Rosa,9 Lotke Tambuyzer,7 Maria Beumont-Mauviel7
1Icahn School of Medicine at Mount Sinai, New York, NY, USA; 2Mediz. Universitatsklinik-Immunologische Ambulanz, Bonn, Germany; 3Royal London Hospital, London, UK; 4Hospital General de Elche and Universidad Miguel Hernández, Alicante, Spain; 5McGill University Health Centre, Montreal, Canada; 6Hopital Gui De Chauliac, Montpellier, France; 7Janssen Infectious Diseases BVBA, Beerse, Belgium; 8Janssen Research & Development, Raritan, NJ, USA; 9Janssen Global Services, Titusville, NJ, USA
|
| |
|
|
|
|
|
